D L. Brautigan

Affiliations: 
University of Virginia, Charlottesville, VA 
Area:
Cell Biology, Microbiology Biology
Google:
"D Brautigan"

Children

Sign in to add trainee
Craig A. Leach grad student 2003 UVA
Nikolaos Tountas grad student 2005 UVA
Todd D. Prickett grad student 2007 UVA
Bjarki Stefansson grad student 2007 UVA
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Griner EM, Dancik GM, Costello JC, et al. (2015) RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer. Molecular Cancer Research : McR. 13: 483-92
Li R, Turner SD, Brautigan DL. (2015) Xanthophylls lutein and zeaxanthin modify gene expression and induce synthesis of hyaluronan in keratinocyte model of human skin Biochemistry and Biophysics Reports. 4: 52-58
Yan C, Liu D, Li L, et al. (2014) Discovery and characterization of small molecules that target the GTPase Ral. Nature. 515: 443-7
Hall EH, Liu Y, Xiao A, et al. (2014) Inhibition of breast cancer metastasis suppressor 1 promotes a mesenchymal phenotype in lung epithelial cells that express oncogenic K-RasV12 and loss of p53. Plos One. 9: e95869
Luz S, Cihil KM, Brautigan DL, et al. (2014) LMTK2-mediated phosphorylation regulates CFTR endocytosis in human airway epithelial cells. The Journal of Biological Chemistry. 289: 15080-93
Dziegielewska B, Brautigan DL, Larner JM, et al. (2014) T-type Ca2+ channel inhibition induces p53-dependent cell growth arrest and apoptosis through activation of p38-MAPK in colon cancer cells. Molecular Cancer Research : McR. 12: 348-58
Sarkar S, Brautigan DL, Parsons SJ, et al. (2014) Androgen receptor degradation by the E3 ligase CHIP modulates mitotic arrest in prostate cancer cells Oncogene. 33: 26-33
Ohama T, Wang L, Griner EM, et al. (2013) Protein Ser/Thr phosphatase-6 is required for maintenance of E-cadherin at adherens junctions. Bmc Cell Biology. 14: 42
Slingluff CL, Petroni GR, Molhoek KR, et al. (2013) Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: A phase II trial (CTEP 7190/Mel47) Clinical Cancer Research. 19: 3611-3620
Korrodi-Gregório L, Ferreira M, Vintém AP, et al. (2013) Identification and characterization of two distinct PPP1R2 isoforms in human spermatozoa. Bmc Cell Biology. 14: 15
See more...